Effect of body mass index on clinical outcomes after robotic cardiac surgery: is there an obesity paradox?

Table 2 Type of robotic cardiac surgery

Variable	Normal	Lean	Overweight and 0bese	P-value
Variable	(n = 81)	(n = 17)	(n = 48)	P-value
ASD, n(%)	37(45.68)	10(58.82)	22(45.83)	0.602
VSD, n(%)	7(8.64)	2(11.76)	1(2.08)	0.255
MVR, n(%)	11(13.58)	11(64.71)	1(2.08)	0.186
MVP, n(%)	7(8.64)	4(23.53)	4(8.33)	0.162
AVR, n(%)	1(1.23)	0(0)	3(6.25)	0.187
TVR, n(%)	2(2.47)	0(0)	0(0)	0.449
LAM, n(%)	12(14.81)	0(0)	5(10.42)	0.215
Concomitant TVP, n(%)	9(11.11)	3(17.65)	8(16.67)	0.600
Others, n(%)	5(6.17)	0(0)	2(4.17)	0.545

ASD Atrial septal defect, AVR Aortic valve replacement, LAM Left atrial myxoma, MVP Mitral valve plasty, MVR Mitral valve replacement, TVP Tricuspid valve plasty, TVR Tricuspid valve replacement, VSD Ventricular septal defect, Others Endocardial cushion defect, Total anomalous pulmonary venous drainage, Left ventricular tumor.

ISSN: 1471-2261